EUVIMEDOpdag EUVIMED
EUVIMED · CrossrefJournal

The Lancet Neurology

ISSN 1474-4422 · Elsevier BV

Latest articles

  1. Safety and efficacy of daily oral edaravone (FNP122) in patients with amyotrophic lateral sclerosis (ADORE): a multicentre, double-blind, phase 3, randomised controlled trial

    Ruben P A van Eijk, Mónica Povedano, Philip Van Damme, Adriano Chiò, Christopher J McDermott, Ammar Al-Chalabi, Orla Hardiman, Carla Varona, Cristina Tarragó, Tania Nadal, Núria Albareda, Leonard H van den Berg, Ammar Al-Chalabi, Calvo Andrea, Jakub Antczak, Shahram Attarian, Lev Brylev, Giuseppe Borghero, Philippe Corcia, Veronique Danel Brunaud, Mamede de Carvalho, Elisa De La Cruz, John Ealing, Rene Guenther, Orla Hardiman, Esther Hobson, Caroline Ingre, Maria Kovalchuk, Magdalena Kuzma-Kozakiewicz, Pawel Lisewski, Albert Ludolph, Christian Lunetta, Jessica Mandrioli, Javier Mascias, Christopher McDermott, Thomas Meyer, Jesus S. Mora Pardina, Carmen Paradas, Julio Pardo Fernandez, Susanne Petri

    Published: 2026-12DOI: 10.1016/s1474-4422(26)00336-4

  2. Application of the 2024 McDonald multiple sclerosis criteria in the international Acute Optic Neuritis Network (ACON): a cross-sectional cohort study

    Philipp Klyscz, Susanna Asseyer, Hadas Stiebel-Kalish, Frederike Cosima Oertel, Ricardo Alonso, Ayse Altintas, Ilya Ayzenberg, John J Chen, Edgar Carnero Contentti, Josep Dalmau, Matteo Gastaldi, Joachim Havla, Christina Mayer, Jyh Yung Hor, Sol Zamir, Sara Mariotto, Cassandra Ocampo, Lekha Pandit, Axel Petzold, Jana Lízrová Preiningerová, Anne-Katrin Pröbstel, Sudarshini Ramanathan, Fu-Dong Shi, Sasitorn Siritho, Angela Vidal-Jordana, Tianrong Yeo, Luis Alfonso Zarco, Jeffrey L Bennett, Friedemann Paul, Adi Wilf-Yarkoni, Carlos Alvarado, Charlotte Bereuter, Omer Bialer, Luca Bollo, Atira Bick, Francesca Bosello, Yolanda Blanco, Eser Bulus, Sara Carta, Fiona Chan

    Published: 2026-12DOI: 10.1016/s1474-4422(26)00352-2

  3. Early middle meningeal artery embolisation plus standard treatment versus standard treatment alone for chronic subdural haematoma in France (OTEMACS): a randomised, open-label, controlled trial

    Sam Ng, Imad Derraz, Gaultier Marnat, Vincent Jecko, Jean Papaxanthos, Guillaume Bellanger, Christophe Cognard, Lubin Klotz, Jean-Christophe Sol, Tuan Le Van, Moncef Berhouma, Pierre Thouant, Timothée Jacquesson, Omer Eker, Hassan El Fertit, David S Liebeskind, Safa Aouinti, Nicolas Molinari, Nicolas Lonjon, Vincent Costalat, Bader Alharbi, Arthur Attal, Xavier Barreau, Medhi Beyragued, Julien Boetto, Fabrice Bonneville, Jérôme Berge, Federico Cagnazzo, Thomas Checkouri, Emilie Chan-Seng, François-Louis Collemiche, Thomas Courret, Emmanuel Cuny, Jean Darcourt, Cyril Dargazanli, Clément Dunoyer, Arthur Durouchoux, Mohamad Ali El Sawalhi, Julien Engelhardt, Elisabeth Fabre

    Published: 2026-12DOI: 10.1016/s1474-4422(26)00360-1

  4. Bridging the gap between dementia risk factors and interventions

    Katrin Seeher, Primrose Nyamayaro, Laura Garcia Diaz, Simone Salemme, Sebastian Köhler, Huali Wang, Tarun Dua, H. Al Hamad, C. Alessi, K.J. Anstey, A. Avan, C.L.A. Bassetti, C.P. Ferri, H. Ibrahim, S. Jhanjee, J.A. Joska, M. Kivipelto, S. Köhler, T. Laatikainen, E. Ong, C. Roberts, R.J Rylett, P.T. Sivakumar, J.D. Steinmetz, K. Suharya, S.P Teo, C.T Udeh-Momoh, H. Wang, S. Watiti, S.S. Williams

    Published: 2026-12DOI: 10.1016/s1474-4422(26)00403-5

  5. Anticoagulants compared with aspirin in patients with embolic strokes of undetermined source: an individual participant data meta-analysis of randomised trials

    Aristeidis H Katsanos, Mukul Sharma, Hans Christoph Diener, Hooman Kamel, Sven Poli, Geoffrey A Donnan, Mitchell S V Elkind, Tobias Geisler, J Donald Easton, David L Tirschwell, Lina María Serna-Higuita, Christopher B Granger, Will T Longstreth, Khouloud Poli, Jeffrey L Saver, Richard A Kronmal, Kazunori Toyoda, Joseph P Broderick, Jordan J Elm, Amanda Taylor, Shofiqul Islam, Lizhen Xu, Robert G Hart, Ashkan Shoamanesh

    Published: 2026-11DOI: 10.1016/s1474-4422(26)00366-2

  6. Safety, tolerability, and efficacy of RIPK1 inhibitor, SAR443820, in amyotrophic lateral sclerosis (HIMALAYA): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

    Merit E Cudkowicz, Jeremy Shefner, Leonard H van den Berg, Adriano Chio, Dongsheng Fan, Julian Großkreutz, Christian Lunetta, Richard M Tsai, Ye Li, Erik Wallstroem, Li Xiong, Yixin Chen, Nazem Atassi, Kristl Claeys, Philip Van Damme, Philippe Beauchemin, Annie Dionne, Oliver Blanchard, Angela Genge, Rami Massie, Jeanne Teitelbaum, Grayson Beecher, Peter Dobrowolski, Wendy Johnston, Michael Nicolle, Christen Shoesmith, Marvin Chum, John Turnbull, Agessandro Abrahao, Antonio Saldanha De Castro Perdo, Isaac Hughes, Dhruv Kumar Jain, Denizart Santos Neto, Lorne Zinman, Yong Chen, Dongsheng Fan, Ji He, Xin Huang, Xiaolu Liu, Yan Ma

    Published: 2026-10DOI: 10.1016/s1474-4422(26)00277-2

Volumes

2026 · 2972025 · 2692024 · 3462023 · 2972022 · 2902021 · 2882020 · 2952019 · 2682018 · 3062017 · 2952016 · 3612015 · 2932014 · 2892013 · 2902012 · 2682011 · 2772010 · 3002009 · 3002008 · 2982007 · 2922006 · 3332005 · 3212004 · 3322003 · 3422002 · 251

Viden, der passer til dit arbejde.

Fra en gratis start over personlig litteratursøgning til den komplette Research Suite.

Se priser →

Er alle forlagsfuldtekster inkluderet?

Nej. Bibliografiske referencer, abstracts og fuldtekster er forskellige typer indhold. Om en fuldtekst er tilgængelig, afhænger af kilden, Open Access og dine eksisterende licenser. Et EUVIMED-abonnement erstatter ikke yderligere forlagsrettigheder.